MODULATION OF BLADDER α1-ADRENERGIC RECEPTOR SUBTYPE EXPRESSION BY BLADDER OUTLET OBSTRUCTION-Reference-Cited by-同舟云学术

MODULATION OF BLADDER α1-ADRENERGIC RECEPTOR SUBTYPE EXPRESSION BY BLADDER OUTLET OBSTRUCTION

Published:2002-03 Issue:3 Volume:167 Page:1513-1521
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

HAMPEL CHRISTIAN¹,DOLBER PAUL C.¹,SMITH MICHAEL P.¹,SAVIC SANDRA L.¹,THÜROFF JOACHIM W.¹,THOR KARL B.¹,SCHWINN DEBRA A.¹

Affiliation:

1. From the Departments of Surgery (Urology), Anesthesiology, Pathology and Pharmacology/Cancer Biology, Duke University Medical Center and Department of Surgery, Durham Veterans Administration Medical Center, Durham, North Carolina, and Urologische Klinik und Poliklinik, Johannes-Gutenberg-Universitat, Mainz, Germany

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference34 articles.

1. Persistence or recurrence of symptoms after transurethral resection of the prostate: a urodynamic assessment;Seaman;J Urol,1994

2. α1-Adrenergic receptor regulation: basic science and clinical implications.;Michelotti;Pharmacol Ther,2000

3. A randomized, placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia;Lepor;J Urol,1992

4. The α1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned α1c subtype;Forray;Mol Pharmacol,1994

5. Blue D.J. Grino P. Jung D. Evaluation of Ro 70-0004, a selective α1a-adrenoceptor antagonist, in men with benign prostatic hyperplasia. Presented at International Consultation on BPH, Paris, France, June 25–28, 2000

Cited by 161 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of disease‐specific quality of life in prostate cancer patients treated with low‐dose‐rate brachytherapy: A randomized controlled trial of silodosin versus naftopidil;International Journal of Urology;2021-08-10

2. Detrusor Overactivity May Be a Prognostic Factor for Better Response to Combination Therapy Over Monotherapy in Male Patients With Benign Prostatic Enlargement and Storage Lower Urinary Tract Symptoms;International Neurourology Journal;2021-03-31

3. Bladder Outlet Obstruction and Overactive Bladder in Males;Non-Neurogenic Bladder Dysfunctions;2021

4. Effects of an alpha-1d adrenoreceptor antagonist (naftopidil) on bladder dysfunction after radiotherapy in female rats;International Urogynecology Journal;2020-08-06

5. Drug Repositioning of the α1-Adrenergic Receptor Antagonist Naftopidil: A Potential New Anti-Cancer Drug?;International Journal of Molecular Sciences;2020-07-27